Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE2.8100
- TODAY'S CHANGE (%)0.0500 (1.8116%)
- Bid / Lots2.6800/ 10
- Ask / Lots3.0000/ 5
- Open / Previous Close2.7300 / 2.7600
- Day Range
- 52 Week Range
- Volume194,133
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 2070 | 2.73 |
| 09:34 ET | 1393 | 2.73 |
| 09:36 ET | 100 | 2.72 |
| 09:38 ET | 200 | 2.729 |
| 09:39 ET | 700 | 2.77 |
| 09:41 ET | 900 | 2.78 |
| 09:43 ET | 536 | 2.78 |
| 09:45 ET | 477 | 2.78 |
| 09:48 ET | 500 | 2.78 |
| 09:50 ET | 624 | 2.79 |
| 09:52 ET | 742 | 2.805 |
| 09:54 ET | 600 | 2.8 |
| 09:57 ET | 100 | 2.809 |
| 09:59 ET | 551 | 2.82 |
| 10:01 ET | 400 | 2.81 |
| 10:03 ET | 900 | 2.797954 |
| 10:06 ET | 200 | 2.79 |
| 10:08 ET | 1550 | 2.7967 |
| 10:10 ET | 100 | 2.8 |
| 10:12 ET | 400 | 2.8 |
| 10:14 ET | 2325 | 2.8 |
| 10:15 ET | 100 | 2.785 |
| 10:17 ET | 100 | 2.7832 |
| 10:21 ET | 1400 | 2.75 |
| 10:24 ET | 500 | 2.76 |
| 10:26 ET | 1300 | 2.78 |
| 10:28 ET | 740 | 2.8 |
| 10:30 ET | 100 | 2.8 |
| 10:32 ET | 634 | 2.796 |
| 10:35 ET | 200 | 2.79 |
| 10:37 ET | 750 | 2.8 |
| 10:39 ET | 200 | 2.81 |
| 10:42 ET | 300 | 2.8 |
| 10:44 ET | 200 | 2.81 |
| 10:46 ET | 200 | 2.81 |
| 10:50 ET | 100 | 2.82 |
| 10:51 ET | 200 | 2.82 |
| 10:55 ET | 200 | 2.81 |
| 10:57 ET | 709 | 2.819 |
| 11:00 ET | 100 | 2.82 |
| 11:04 ET | 100 | 2.82 |
| 11:08 ET | 100 | 2.82 |
| 11:09 ET | 300 | 2.82 |
| 11:11 ET | 200 | 2.8 |
| 11:13 ET | 200 | 2.82 |
| 11:18 ET | 200 | 2.819 |
| 11:20 ET | 200 | 2.82 |
| 11:22 ET | 500 | 2.81 |
| 11:24 ET | 1500 | 2.8 |
| 11:26 ET | 100 | 2.8 |
| 11:29 ET | 100 | 2.8 |
| 11:31 ET | 1086 | 2.83 |
| 11:36 ET | 100 | 2.84 |
| 11:40 ET | 100 | 2.84 |
| 11:42 ET | 1131 | 2.8244 |
| 11:45 ET | 200 | 2.83 |
| 11:47 ET | 100 | 2.825 |
| 11:49 ET | 211 | 2.825 |
| 11:51 ET | 200 | 2.825 |
| 11:54 ET | 100 | 2.825 |
| 11:58 ET | 100 | 2.83 |
| 12:00 ET | 624 | 2.85 |
| 12:02 ET | 100 | 2.85 |
| 12:03 ET | 100 | 2.85 |
| 12:09 ET | 200 | 2.85 |
| 12:12 ET | 200 | 2.86 |
| 12:16 ET | 100 | 2.87 |
| 12:20 ET | 100 | 2.87 |
| 12:21 ET | 2045 | 2.86 |
| 12:23 ET | 100 | 2.87 |
| 12:25 ET | 2101 | 2.83 |
| 12:36 ET | 400 | 2.8 |
| 12:38 ET | 21313 | 2.8358 |
| 12:39 ET | 5398 | 2.82 |
| 12:41 ET | 100 | 2.82 |
| 12:43 ET | 100 | 2.815 |
| 12:45 ET | 100 | 2.815 |
| 12:48 ET | 1400 | 2.81 |
| 12:50 ET | 1441 | 2.8 |
| 12:52 ET | 200 | 2.79 |
| 12:54 ET | 1668 | 2.7839 |
| 12:56 ET | 1913 | 2.79 |
| 12:57 ET | 600 | 2.8 |
| 12:59 ET | 100 | 2.8 |
| 01:01 ET | 100 | 2.8 |
| 01:03 ET | 200 | 2.8 |
| 01:10 ET | 100 | 2.8 |
| 01:14 ET | 100 | 2.81 |
| 01:15 ET | 1858 | 2.8 |
| 01:19 ET | 200 | 2.8 |
| 01:24 ET | 100 | 2.81 |
| 01:26 ET | 100 | 2.81 |
| 01:30 ET | 360 | 2.8 |
| 01:32 ET | 700 | 2.785 |
| 01:33 ET | 1332 | 2.8 |
| 01:35 ET | 348 | 2.79 |
| 01:37 ET | 200 | 2.8 |
| 01:42 ET | 100 | 2.8 |
| 01:44 ET | 100 | 2.81 |
| 01:46 ET | 100 | 2.81 |
| 01:48 ET | 100 | 2.81 |
| 01:51 ET | 200 | 2.8 |
| 01:53 ET | 500 | 2.8 |
| 01:55 ET | 3871 | 2.8 |
| 01:57 ET | 400 | 2.8 |
| 02:02 ET | 1400 | 2.795 |
| 02:04 ET | 300 | 2.8 |
| 02:06 ET | 805 | 2.8 |
| 02:08 ET | 200 | 2.8 |
| 02:09 ET | 300 | 2.8 |
| 02:11 ET | 130 | 2.8 |
| 02:13 ET | 100 | 2.8 |
| 02:15 ET | 200 | 2.8 |
| 02:18 ET | 2600 | 2.8 |
| 02:22 ET | 400 | 2.795 |
| 02:24 ET | 700 | 2.795 |
| 02:26 ET | 639 | 2.8 |
| 02:33 ET | 610 | 2.8 |
| 02:36 ET | 450 | 2.8 |
| 02:38 ET | 1515 | 2.795 |
| 02:40 ET | 873 | 2.795 |
| 02:42 ET | 600 | 2.8 |
| 02:44 ET | 2020 | 2.8 |
| 02:45 ET | 100 | 2.8 |
| 02:51 ET | 600 | 2.8 |
| 02:54 ET | 100 | 2.81 |
| 02:56 ET | 383 | 2.81 |
| 02:58 ET | 100 | 2.81 |
| 03:00 ET | 625 | 2.81 |
| 03:02 ET | 517 | 2.82 |
| 03:03 ET | 700 | 2.81 |
| 03:05 ET | 100 | 2.815 |
| 03:07 ET | 100 | 2.815 |
| 03:09 ET | 100 | 2.815 |
| 03:12 ET | 100 | 2.81 |
| 03:14 ET | 200 | 2.81 |
| 03:16 ET | 100 | 2.815 |
| 03:18 ET | 500 | 2.8 |
| 03:20 ET | 200 | 2.805 |
| 03:21 ET | 1604 | 2.8 |
| 03:23 ET | 300 | 2.8 |
| 03:27 ET | 600 | 2.8 |
| 03:30 ET | 300 | 2.8 |
| 03:32 ET | 400 | 2.8 |
| 03:34 ET | 397 | 2.8 |
| 03:36 ET | 500 | 2.8 |
| 03:38 ET | 1298 | 2.8 |
| 03:39 ET | 200 | 2.8 |
| 03:41 ET | 1812 | 2.795 |
| 03:43 ET | 2095 | 2.81 |
| 03:45 ET | 300 | 2.805 |
| 03:48 ET | 928 | 2.81 |
| 03:50 ET | 300 | 2.81 |
| 03:52 ET | 3238 | 2.815 |
| 03:54 ET | 2564 | 2.81 |
| 03:56 ET | 2706 | 2.8 |
| 03:57 ET | 8645 | 2.8 |
| 03:59 ET | 3782 | 2.81 |
May 29, 2024
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences, from 4:36PM ET on Wednesday May 29, 2024 by Dow Jones
4:36PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 147.6M | -0.6x | --- |
Context Therapeutics Inc | 147.0M | -1.5x | --- |
Boundless Bio Inc | 146.0M | 0.0x | --- |
Atossa Therapeutics Inc | 150.9M | -5.1x | --- |
Compass Therapeutics Inc. | 152.7M | -3.2x | --- |
Regulus Therapeutics Inc | 157.8M | -1.7x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Lead Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $147.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.40 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
